Jonathan W. Ayers, Director at IDEXX LABORATORIES INC /DE (IDXX), sold 42,260 shares at $292.44 ($12.3M) on 2020-05-08, disclosed to the SEC on 2020-05-12.
Open-market sale of $12.3M IDXX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $290.59 | 5,136 | $1.5M | 12.1% |
| 2 | $290.59 | 5,136 | $1.5M | 12.1% |
| 3 | $291.41 | 9,953 | $2.9M | 23.5% |
| 4 | $291.41 | 9,953 | $2.9M | 23.5% |
| 5 | $292.44 | 3,440 | $1.0M | 8.2% |
| 6 | $292.44 | 3,440 |
| $1.0M |
| 8.2% |
| 7 | $293.40 | 2,601 | $763K | 6.2% |
| 8 | $293.40 | 2,601 | $763K | 6.2% |
| Total | $291.62 avg | 42,260 | $12.3M | 100% |
| Filing → |
| IDXX | SELL | 2021-06-01 | $9.9M | — | Filing → |
| IDXX | SELL | 2021-05-26 | $5.5M | — | Filing → |
| IDXX | SELL | 2021-05-24 | $5.4M | — | Filing → |